|23rd July 2020||William Edward Mc Kechnie||110,000||Exercise of derivative||$0.17||$19,030.00|
|6th May 2020||Christopher Bunka||200,000||Grant/award etc.||$0.23||$46,000.00|
|20th December 2019||Nicholas W Baxter||110,000||Exercise of derivative||$0.10||$11,000.00|
|15th February 2019||Allan Horst Spissinger||50,000||Exercise of derivative||$0.37||$18,500.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Lexaria Bioscience Corp. engages in the development of strategic partnerships and in the proprietary nutrient infusion technologies for the production of superfoods. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.